Lumibird S.A (LBIRD) | Stock Overview & Key Data
Lumibird S.A. | Mid-cap | Healthcare
Lumibird S.A. | Mid-cap | Healthcare
Lumibird S.A Performance Comparison
Stock Range
Today's Range
Low: €19.40
High: €20.20
on August 8, 2025
52 Week Range
Low: €6.78
High: €21.40
on October 18, 2024
on August 5, 2025
All-Time High: €24.35 on December 27, 2021
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€441.2M
EPS
0.26
P/E Ratio (TTM)
76.35
Forward P/E
36.09
P/B Ratio
2.21
PEG Ratio
36.09
Div. Yield
N/A
ROE
2.91%
Beta
1.097
Debt to Equity
81.34
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
12.01%
Profit Margin
2.71%
Returns and Earnings
Return on Assets (TTM)
2.23%
Return on Equity (TTM)
2.91%
EBITDA
€34.5M
Net Income (TTM)
€5.7M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€9.54
Quarterly Revenue Growth (YoY)
2.50%
Quarterly Earnings Growth (YoY)
-12.30%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Lumibird S.A LBIRD | 441.19M Mid-cap | 4.51% | 8.84% | 69.83% | 159.21% | 105.21% | 98.59% | -10.05% | 64.72% |
| bioMérieux S.A BIM | 14.53B Large-cap | 0.48% | 4.79% | 7.78% | 8.43% | 21.42% | 28.16% | 22.08% | -9.64% |
| Eurofins Scientific ERF | 11.98B Large-cap | 0.82% | 11.36% | 18.42% | 28.90% | 36.27% | 25.78% | -12.14% | 1.43% |
| Eurofins Cerep SAS ALECR | 88.77M Small-cap | -3.83% | 0.00% | -14.56% | -14.56% | -10.20% | -10.66% | -13.73% | 162.69% |
| Klea Holding ALKLH | 59.69M Small-cap | 0.00% | 5.56% | 5.56% | 0.00% | 11.76% | 11.76% | 0.00% | 0.00% |
| Predilife S.A ALPRE | 12.80M Small-cap | -4.52% | -6.11% | -8.40% | -11.05% | -5.06% | -28.69% | -44.59% | -54.32% |
Ownership & Short Interest
Insider Ownership
56.75%
Institutional Ownership
15.54%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
41K
Average 90-Day Volume
41K
Lumibird S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Lumibird S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is LBIRD's 52-week high and low?
- In the last 52 weeks, Lumibird S.A reached a high of €21.40 (on August 5, 2025) and a low of €6.78 (on October 18, 2024).
- What is the market cap and P/E ratio for LBIRD?
- Curious about Lumibird S.A's size and valuation? Its market capitalization stands at 441.19M. When it comes to valuation, the P/E ratio (trailing twelve months) is 76.35, and the forward P/E (looking ahead) is 36.09.
- Does LBIRD pay dividends? If so, what's the yield?
- As for dividends, Lumibird S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Lumibird S.A's main competitors or similar companies to consider before investing?
When looking at Lumibird S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return bioMérieux S.A
BIM14.53B Healthcare Diagnostics & Research 28.16% 22.08% Eurofins Scientific
ERF11.98B Healthcare Diagnostics & Research 25.78% -12.14% Eurofins Cerep SAS
ALECR88.77M Healthcare Diagnostics & Research -10.66% -13.73% Klea Holding
ALKLH59.69M Healthcare Diagnostics & Research 11.76% 0.00% Predilife S.A
ALPRE12.80M Healthcare Diagnostics & Research -28.69% -44.59% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Lumibird S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Lumibird S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 2.91%, the Debt to Equity ratio from the most recent quarter is 81.34, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for LBIRD?
- Looking at Lumibird S.A's growth, its revenue over the trailing twelve months (TTM) was €210M. Compared to the same quarter last year (YoY), quarterly revenue grew by 2.50%, and quarterly earnings saw a YoY growth of -12.30%.
- How much of LBIRD stock is held by insiders and institutions?
- Wondering who owns Lumibird S.A stock? Company insiders (like executives and directors) hold about 56.75% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 15.54%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.